+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis



Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis



Cellular Physiology and Biochemistry 46(4): 1331-1340



Diabetic nephropathy (DN), a major diabetic microvascular complication, has a long and growing list of biomarkers, including microRNA biomarkers, which have not been consistent across preclinical and clinical studies. This meta-analysis aims to identify significant blood- and urine-incident microRNAs as diagnostic/prognostic biomarker candidates for DN. PubMed, Web of Science, and Cochrane Library were searched from their earliest records through 12th Dec 2016. Relevant publications for the meta-analysis included (1) human participants; (2) microRNAs in blood and urine; (3) DN studies; and (4) English language. Four reviewers, including two physicians, independently and blindly extracted published data regarding microRNA profiles in blood and/or urine from subjects with diabetic nephropathy. A random-effect model was used to pool the data. Statistical associations between diabetic nephropathy and urinary or blood microRNA expression levels were assessed. Fourteen out of 327 studies (n=2,747 patients) were selected. Blood or urinary microRNA expression data of diabetic nephropathy were pooled for this analysis. The hsa-miR-126 family was significantly (OR: 0.57; 95% CI: 0.44-0.74; p-value < 0.0001) downregulated in blood from patients with diabetic kidney disease, while its urinary level was upregulated (OR: 2931.12; 95% CI: 9.96-862623.21; p-value = 0.0059). The hsa-miR-770 family microRNA were significantly (OR: 10.24; 95% CI: 2.37-44.25; p-value = 0.0018) upregulated in both blood and urine from patients with diabetic nephropathy. Our meta-analysis suggests that hsa-miR-126 and hsa-miR-770 family microRNA may have important diagnostic and pathogenetic implications for DN, which warrants further systematic clinical studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065655229

Download citation: RISBibTeXText

PMID: 29689545

DOI: 10.1159/000489148


Related references

Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats. Plos One 11(4): E0154055-E0154055, 2016

Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Experimental and Therapeutic Medicine 12(2): 815-822, 2016

Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis. Medicine 95(2): E2450-E2450, 2016

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy. Clinical Kidney Journal 7(4): 354-360, 2015

Urinary Heme Oxygenase-1 as a potential biomarker for early diabetic nephropathy. Nephrology (): -, 2016

MicroRNA-150 as a Potential Biomarker in Diagnosis of Cancer: a Meta-Analysis. Clinical Laboratory 63(7): 1187-1197, 2018

Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies. Journal of Nephrology: -, 2018

A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer. Cellular and Molecular Biology 64(6): 86-93, 2018

Peripheral Blood Mitochondrial DNA Damage as a Potential Noninvasive Biomarker of Diabetic Retinopathy. Investigative Ophthalmology & Visual Science 57(10): 4035-4044, 2017

Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials. Plos One 11(2): E0149513-E0149513, 2016

Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis. Biomed Research International 2017: 1875843-1875843, 2017

Potential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-Analysis. Biomed Research International 2015: 303987-303987, 2016

MicroRNA-23a/24-2/27a as a potential diagnostic biomarker for cancer: A systematic review and meta-analysis. Molecular and Clinical Oncology 8(1): 159-169, 2018

Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis. Molecules 19(5): 6282-6293, 2014

MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis. Plos One 9(2): E88745-E88745, 2014